Cyclophosphamide does not benefit patients with focal segmental glomerulosclerosis. A report of the International Study of Kidney Disease in Children.
Saved in:
| Title: | Cyclophosphamide does not benefit patients with focal segmental glomerulosclerosis. A report of the International Study of Kidney Disease in Children. |
|---|---|
| Authors: | Tarshish P; Albert Einstein College of Medicine, Bronx, New York, USA., Tobin JN, Bernstein J, Edelmann CM Jr |
| Source: | Pediatric nephrology (Berlin, Germany) [Pediatr Nephrol] 1996 Oct; Vol. 10 (5), pp. 590-3. |
| Publication Type: | Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. |
| Journal Info: | Publisher: Springer International Country of Publication: Germany NLM ID: 8708728 Publication Model: Print Cited Medium: Print ISSN: 0931-041X (Print) Linking ISSN: 0931041X NLM ISO Abbreviation: Pediatr Nephrol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
